n-acetylneuraminic acid has been researched along with Blood Pressure, High in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (6.67) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Banerjee, S; Chambliss, KL; Chu, H; Kifer, D; Lauc, G; Mineo, C; Peng, J; Polasek, O; Rohatgi, A; Sacharidou, A; Shaul, PW; Sundgren, NC; Tanigaki, K; Vongpatanasin, W; Yuhanna, IS | 1 |
Dobrzyńska, I; Figaszewski, ZA; Pędzińska-Betiuk, A; Skrzydlewska, E; Szachowicz-Petelska, B | 1 |
Dobrzyńska, I; Figaszewski, ZA; Skrzydlewska, E; Szachowicz-Petelska, B; Weresa, J | 1 |
Jawed, M; Mahboob, T; Shahid, SM | 1 |
Jinghua, L; Ping, W; Tie, Z; Yongtong, C | 1 |
Barberena, L; Carrera, L; D'Arrigo, M; Foresto, P; Lebensohn, N; Re, A | 1 |
Mahboob, T; Nawab, SN; Shahid, SM; Shaikh, R | 1 |
GALEEVA, MG | 1 |
Browning, LM; Cooke, JH; Crook, MA; Jebb, SA; Krebs, JD; Mishra, GD; O'Connell, MA | 1 |
Burt, D; Chusney, GD; Crook, MA; Fitzgerald, AP; Mattock, MB; Pickup, JC | 1 |
Imiya, M; Kario, K; Kayaba, K; Kuroda, T; Matsuo, H; Matsuo, T; Nago, N; Shimada, K | 1 |
Dahlöf, C; Nederfors, T | 1 |
Burke, GL; Folsom, AR; Lindberg, G; Lundblad, A; Nilsson-Ehle, P; Råstam, L | 1 |
Crook, MA; Fuller, JH; Georgino, F; Giorgino, F; Lumb, PJ; Pickup, JC; Webb, DJ | 1 |
Arima, T; Kuriyama, M; Miyahara, K; Miyauchi, T; Nagata, K; Nakamura, K; Osame, M; Sakamoto, K; Sanada, J; Sonoda, M | 1 |
15 other study(ies) available for n-acetylneuraminic acid and Blood Pressure, High
Article | Year |
---|---|
Supplementation With the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension.
Topics: Animals; Dietary Supplements; Endothelial Cells; Hexosamines; Hypertension; Immunoglobulin G; Male; Mice, Inbred C57BL; N-Acetylneuraminic Acid; Obesity; Receptors, IgG | 2019 |
Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Disease Models, Animal; Erythrocyte Membrane; Hypertension; Lipid Peroxidation; Male; N-Acetylneuraminic Acid; Oxidative Stress; Rats; Rats, Inbred SHR | 2020 |
Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Cell Membrane; Chromatography, High Pressure Liquid; Desoxycorticosterone Acetate; Disease Models, Animal; Enzyme Inhibitors; Hypertension; Kidney; Lipid Peroxidation; Male; N-Acetylneuraminic Acid; Phospholipids; Rats; Rats, Inbred SHR; Rats, Wistar | 2019 |
Relationship between serum nitric oxide and sialic acid in coexisted diabetes, hypertension and nephropathy.
Topics: Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus; Diabetic Nephropathies; Fasting; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypertension; Male; Middle Aged; N-Acetylneuraminic Acid; Nitric Oxide; Renal Insufficiency; Urea | 2013 |
The relationship between serum sialic acid and high-sensitivity C-reactive protein with prehypertension.
Topics: Blood Pressure; C-Reactive Protein; Case-Control Studies; Diastole; Humans; Hypertension; Linear Models; N-Acetylneuraminic Acid; Prehypertension; Systole | 2014 |
[Serum sialic acid, cellular anionic charge and erythrocyte aggregation in diabetic and hypertensive patients].
Topics: Adult; Aged; Anions; Case-Control Studies; Diabetes Mellitus; Erythrocyte Aggregation; Female; Humans; Hypertension; Male; Middle Aged; N-Acetylneuraminic Acid | 2009 |
Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Topics: Albuminuria; Blood Glucose; Cholesterol; Creatinine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dyslipidemias; Female; Glycated Hemoglobin; Humans; Hypertension; Male; Middle Aged; N-Acetylneuraminic Acid; Nitric Oxide; Triglycerides; Urea | 2012 |
[CONTENT OF SIALIC ACID IN THE BLOOD SERUM IN HYPERTENSION AND RENAL HYPERTENSION].
Topics: Blood Chemical Analysis; Diagnosis, Differential; Hypertension; Hypertension, Renal; Kidney; N-Acetylneuraminic Acid; Nephritis; Neuraminic Acids; Serum | 1963 |
Elevated sialic acid, but not CRP, predicts features of the metabolic syndrome independently of BMI in women.
Topics: Adult; Aged; Analysis of Variance; Biomarkers; Body Mass Index; C-Reactive Protein; Contraceptives, Oral; Estrogen Replacement Therapy; Female; Humans; Hyperlipidemias; Hypertension; Insulin Resistance; Metabolic Syndrome; Middle Aged; N-Acetylneuraminic Acid; Odds Ratio; Risk | 2004 |
Serum sialic acid concentration and coronary heart disease in NIDDM.
Topics: Adult; Age Factors; Apolipoproteins; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Glycated Hemoglobin; Humans; Hypertension; Lipoproteins; Male; Middle Aged; Multivariate Analysis; N-Acetylneuraminic Acid; Odds Ratio; Reference Values; Regression Analysis; Sex Characteristics; Sialic Acids; Triglycerides | 1995 |
Close relation between lipoprotein (a) levels and atherothrombotic disease in Japanese subjects > 75 years of age.
Topics: Aged; Aged, 80 and over; Aging; Arteriosclerosis; Cerebral Infarction; Cholesterol; Cohort Studies; Coronary Disease; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Japan; Lipoprotein(a); Male; Middle Aged; N-Acetylneuraminic Acid; Risk Factors; Sialic Acids | 1994 |
Effects on salivary flow rate and composition of withdrawal of and re-exposure to the beta 1-selective antagonist metoprolol in a hypertensive patient population.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Amylases; Antihypertensive Agents; Blood Pressure; Calcium; Citric Acid; Female; Follow-Up Studies; Hexosamines; Humans; Hypertension; Male; Mastication; Metoprolol; Middle Aged; N-Acetylneuraminic Acid; Parotid Gland; Phosphates; Potassium; Saliva; Salivary Proteins and Peptides; Secretory Rate; Sublingual Gland; Submandibular Gland | 1996 |
Association between serum sialic acid concentration and carotid atherosclerosis measured by B-mode ultrasound. The ARIC Investigators. Atherosclerosis Risk in Communities Study.
Topics: Arteriosclerosis; Carotid Arteries; Carotid Artery Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypertension; Insulin; Longitudinal Studies; Male; Middle Aged; N-Acetylneuraminic Acid; Odds Ratio; Risk Factors; Smoking; Ultrasonography | 1996 |
Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
Topics: Adult; Albuminuria; Body Constitution; Cholesterol; Coronary Disease; Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exercise; Female; Glycated Hemoglobin; Humans; Hypertension; Logistic Models; Male; N-Acetylneuraminic Acid; Risk Factors; Smoking; Triglycerides | 2001 |
Changes in serum lipoprotein(a) and C4b-binding protein levels after acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Apolipoproteins; C-Reactive Protein; Carrier Proteins; Complement Inactivator Proteins; Diabetes Complications; Female; Glycoproteins; Haptoglobins; Humans; Hypertension; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; N-Acetylneuraminic Acid; Sialic Acids; Thrombolytic Therapy | 1992 |